Sectoral Asset Management’s Indaptus Therapeutics INDP Stock Holding History

Sectoral Asset Management’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-392	Closed	-$3.81M	–	75
2019 Q2	$3.81M	Buy	392 +31	+9%	+$391K	0.46%	59
2019 Q1	$5.93M	Sell	361 -133	-27%	-$2.33M	0.71%	51
2018 Q4	$8.34M	Sell	494 -31	-6%	-$423K	1.13%	32
2018 Q3	$6.65M	Buy	525 +128	+32%	+$1.22M	0.71%	46
2018 Q2	$3.92M	Buy	397 +196	+98%	+$2.17M	0.44%	55
2018 Q1	$2.85M	Buy	201 +43	+27%	+$609K	0.31%	60
2017 Q4	$1.83M	Hold	158	–	–	0.23%	58
2017 Q3	$3.18M	Buy	+158	New	+$2.28M	0.41%	49

Other funds holding INDP

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Sectoral Asset Management's INDP Position: Q3 2019 in Review

Sectoral Asset Management sold out of Indaptus Therapeutics (INDP) in Q3 2019, closing a stake of 392 shares — an estimated $3.81M sold.

Sectoral Asset Management first reported a position in INDP in Q3 2017 and held it in 8 quarters. The position peaked at $8.34M in Q4 2018. 33 funds tracked by Wall St. Rank hold INDP as of Q3 2019.

Sectoral Asset Management reported no remaining Indaptus Therapeutics position as of Q3 2019 after selling out during the quarter.
Sectoral Asset Management sold 392 Indaptus Therapeutics shares in Q3 2019, an estimated $3.81M.
Sectoral Asset Management first reported a position in Indaptus Therapeutics in Q3 2017 and held it in 8 quarters.
Sectoral Asset Management's Indaptus Therapeutics position peaked at $8.34M in Q4 2018.
33 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2019.

Based on Sectoral Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.